With AGE-BSA treatment, we found co-localization of LAMP-1 and CML in the HUVECs with AGE-BSA treatment alone, but not in the cells with AGE-BSA and FIR treatments (Fig. 4c). The gene discussed is LAMP1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.